Spectrum (SPPI) Earnings And Sales Beat Estimates In Q1
Spectrum Pharmaceuticals, Inc. (SPPI – Free Report) incurred a loss of 16 cents per share in the first quarter of 2018, narrower than the Zacks Consensus Estimate of a loss of 24 cents and the year-ago quarter loss of 30 cents per share. However, adjusted loss came in at 15 cents, wider-than the year ago…